Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Skin problems after waxing led to a sarcoidosis diagnosis.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Caffeine may help reduce stress-induced hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The guide helps dermatologists diagnose and treat different types of hair loss.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

New therapies are being developed that target integrin pathways to treat various diseases.

Testosterone may influence COVID-19 severity and outcomes.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.